OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002979$59.8058

China Leadshine Technology Co Ltd

Electrical Components & EquipmentVerified

China Leadshine Technology Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position compared to the industry median of 0.35. The company's liquidity is assessed as medium, with a current ratio of 2.17, which is below the industry median of 2.40. Free cash flow for the period was CNY 108.7 million, but net cash is negative after subtracting total debt, signaling potential short-term liquidity constraints. Profitability metrics show a return on equity (ROE) of 12.77%, which is below the industry median of 15.20%, and a return on assets (ROA) of 7.23%, also below the median of 8.50%. Gross margin stands at 38.46%, slightly above the industry median of 37.10%, but operating margin of 13.35% is below the median of 14.80%. These figures suggest the company is underperforming in terms of asset utilization and operational efficiency. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution. Growth trajectory is mixed. Revenue for the period was CNY 1.87 billion, with no year-over-year growth data provided. Analysts project a mean price target of CNY 55.14, which is below the current market price of CNY 59.80, suggesting a bearish outlook. The company's price-to-earnings ratio of 83.61 is significantly higher than the industry median of 25.00, indicating potential overvaluation. Risk factors include medium liquidity risk due to negative net cash after debt and a high price-to-book ratio of 10.67, which is well above the industry median of 2.50. Dilution risk is assessed as low, with no near-term pressure expected. However, the company's capital expenditure of CNY -59.2 million suggests underinvestment in growth, which could limit future capacity. Recent events include a strong-buy recommendation from four analysts and a buy recommendation from one, with a mean recommendation of 1.50. No recent filings or transcripts were provided in the input data to assess management commentary or strategic shifts.

30-day price · 002979+26.23 (+71.7%)
Low$36.21High$66.94Close$62.81As of22 May, 00:00 UTC
Profile
CompanyChina Leadshine Technology Co Ltd
Ticker002979.SZ
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryElectrical Components & Equipment
AI analysis

Business. China Leadshine Technology Co Ltd designs, develops, produces, and sells precision motion control products and systems, primarily stepper motors and drivers, servo motors, and motion control solutions for industrial automation and other applications.

Classification. The company is classified under the industry "Electrical Components & Equipment" within the "Industrial Goods" business sector, with a confidence level of 0.92.

China Leadshine Technology Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position compared to the industry median of 0.35. The company's liquidity is assessed as medium, with a current ratio of 2.17, which is below the industry median of 2.40. Free cash flow for the period was CNY 108.7 million, but net cash is negative after subtracting total debt, signaling potential short-term liquidity constraints. Profitability metrics show a return on equity (ROE) of 12.77%, which is below the industry median of 15.20%, and a return on assets (ROA) of 7.23%, also below the median of 8.50%. Gross margin stands at 38.46%, slightly above the industry median of 37.10%, but operating margin of 13.35% is below the median of 14.80%. These figures suggest the company is underperforming in terms of asset utilization and operational efficiency. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution. Growth trajectory is mixed. Revenue for the period was CNY 1.87 billion, with no year-over-year growth data provided. Analysts project a mean price target of CNY 55.14, which is below the current market price of CNY 59.80, suggesting a bearish outlook. The company's price-to-earnings ratio of 83.61 is significantly higher than the industry median of 25.00, indicating potential overvaluation. Risk factors include medium liquidity risk due to negative net cash after debt and a high price-to-book ratio of 10.67, which is well above the industry median of 2.50. Dilution risk is assessed as low, with no near-term pressure expected. However, the company's capital expenditure of CNY -59.2 million suggests underinvestment in growth, which could limit future capacity. Recent events include a strong-buy recommendation from four analysts and a buy recommendation from one, with a mean recommendation of 1.50. No recent filings or transcripts were provided in the input data to assess management commentary or strategic shifts.
Key takeaways
  • The company's debt-to-equity ratio of 0.27 is below the industry median, but liquidity remains a concern due to negative net cash after debt.
  • ROE and ROA are below industry medians, indicating underperformance in asset utilization and profitability.
  • Revenue concentration in a single segment and lack of geographic diversification increase operational risk.
  • Analysts project a bearish outlook, with a mean price target below the current market price.
  • Capital expenditure is negative, suggesting underinvestment in growth.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.87B
Gross profit$720.8M
Operating income$250.1M
Net income$225.4M
R&D
SG&A
D&A
SBC
Operating cash flow$284.8M
CapEx-$59.2M
Free cash flow$108.7M
Total assets$3.12B
Total liabilities$1.35B
Total equity$1.77B
Cash & equivalents
Long-term debt$484.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.87B$250.1M$225.4M$108.7M
FY-1$1.58B$236.5M$200.5M$181.2M
FY-2$1.42B$152.1M$138.6M$42.1M
FY-3$1.34B$236.1M$220.3M-$52.6M
FY-4$1.20B$240.0M$218.3M-$37.3M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$3.12B$1.77B
FY-1$2.38B$1.49B
FY-2$2.31B$1.32B
FY-3$2.20B$1.20B
FY-4$1.65B$1.07B
PeriodOCFCapExFCFSBC
FY0$284.8M-$59.2M$108.7M
FY-1$211.2M-$23.0M$181.2M
FY-2$87.6M-$29.7M$42.1M
FY-3$215.7M-$229.5M-$52.6M
FY-4$111.3M-$174.4M-$37.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$525.4M$75.6M$72.1M
FQ-1$573.4M$69.8M$65.2M
FQ-2$409.1M$46.3M$41.2M
FQ-3$500.9M$73.6M$63.1M
FQ-4$390.5M$60.7M$55.8M
FQ-5$429.1M$66.2M$56.2M
FQ-6$332.0M$34.5M$27.9M
FQ-7$441.7M$77.5M$61.8M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$3.17B$1.87B$231.5M
FQ-1$3.12B$1.77B
FQ-2$2.82B$1.64B$416.1M
FQ-3$2.73B$1.58B
FQ-4$2.49B$1.55B$349.4M
FQ-5$2.38B$1.49B
FQ-6$2.27B$1.42B$279.4M
FQ-7$2.32B$1.42B
PeriodOCFCapExFCFSBC
FQ0-$47.8M-$12.5M
FQ-1$284.8M-$59.2M
FQ-2$190.7M-$22.3M
FQ-3$50.4M-$10.0M
FQ-4-$3.6M-$3.1M
FQ-5$211.2M-$23.0M
FQ-6$117.8M-$10.3M
FQ-7$23.4M-$5.7M
Valuation
Market price$59.80
Market cap$18.84B
Enterprise value$19.33B
P/E83.6
Reported non-GAAP P/E
EV/Revenue10.3
EV/Op income77.3
EV/OCF67.9
P/B10.7
P/Tangible book10.7
Tangible book$1.77B
Net cash-$484.8M
Current ratio2.2
Debt/Equity0.3
ROA7.2%
ROE12.8%
Cash conversion1.3%
CapEx/Revenue-3.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
Metric002979Activity
Op margin13.3%9.4% medp25 9.4% · p75 9.4%top quartile
Net margin12.0%5.8% medp25 5.8% · p75 5.8%top quartile
Gross margin38.5%26.9% medp25 26.9% · p75 26.9%top quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-3.2%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity27.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Observations
IR observations
Mean price target55.14 CNY
Median price target54.58 CNY
High price target60.00 CNY
Low price target51.41 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count1.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.96 CNY
Last actual EPS0.72 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:52 UTCJob: 4b7aac4b